Frontenac completes sale of Crescent Healthcare to Walgreens
February 06, 2012
Walgreens (NYSE:WAG) has acquired Crescent, a provider of specialty home infusion services with a particular focus on chronic, high-cost diseases. Frontenac initially invested in Crescent in 2004, and since that time the company has doubled in size. Walgreens is the nation's largest drugstore chain, and also offers specialty and mail order pharmacy services.